Saturday, July 27, 2024

EU regulator rejects Alzheimer's drug lecanemab

Posted by AST on 12:31 AM with No comments
It said the benefits of the treatment did not outweigh the risk of serious side effects.

from BBC News https://ift.tt/R7fNXBe
Categories: ,

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)